Skip to main content
OpenTrials

Clinical trial condition

Gastric Cancer

Explore clinical trials studying Gastric Cancer. Study availability and eligibility vary by location and protocol.

1,116 public trials 273 recruiting studies
Refine in advanced search Browse all conditions

Gastric Cancer trial results

Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

NCT05159440

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

NCT03760822

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +9 more
Locations
  • CH - Abbeville, France
  • CH - Albi Albi, France
  • PRIVEE - L'Europe Amiens, France
  • CAC - ICO Site Paul Papin Angers, France
View all 38 locations
View Trial Details
Active, Not Recruiting

Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

NCT03959293

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations
  • Ch - Centre Hospitalier Abbeville, France
  • Ch - Hôpital Claude Bernard Albi, France
  • Chu - Hôpital Sud Amiens, France
  • Privé - Clinique de L'Europe Amiens, France
View all 35 locations
View Trial Details

Related conditions